Liafensine
id:
liafensine-235-1373779
title:
Liafensine
text:
Liafensine (BMS-820836) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) which was under development by Bristol-Myers Squibb for the treatment of major depressive disorder. Though it demonstrated comparable effectiveness to escitalopram and duloxetine in phase II clinical trials, development was paused in 2013 because liafensine failed to show superior effectiveness relative to these drugs, a decision that was made likely based on its increased capacity for side effects as well
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Liafensine
date created:
date modified:
2023-12-05T02:17:19Z
main entity:
{"identifier":"Q18353685","url":"https://www.wikidata.org/entity/Q18353685"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2c/Liafensine.svg","width":1275,"height":1310}
fields total:
13
integrity:
15